Cited by 30Chemotherapy-induced cardiotoxicity and mitigationCardiac Imaging and DiagnosticsCardiac tumors and thrombi

Cardiovascular Risk Stratification by Automatic Coronary Artery Calcium Scoring on Pretreatment Chest Computed Tomography in Diffuse Large B-Cell Lymphoma Receiving Anthracycline-Based Chemotherapy: A Multicenter Study

Shen, Hesong, Lian, Yanbang, Yin, Jinxue, Zhu, Minghong, Yang, Chun, Tu, Chunrong, Peng, Yangling, Li, Xiaoqin +1 more·2023·Circulation: Cardiovascular Imaging

Abstract

Background: Balancing the cardiovascular risk and benefit of anthracycline-based chemotherapy in patients with diffuse large B-cell lymphoma is an important clinical issue. We aimed to evaluate whether the pretreatment coronary artery calcium score (CACS) can stratify the risk of cancer therapy-related cardiac dysfunction (CTRCD) and major adverse cardiovascular events (MACEs) in patients with diffuse large B-cell lymphoma receiving anthracycline-based chemotherapy. Methods: The patients with diffuse large B-cell lymphoma from 4 hospitals were retrospectively enrolled. The CACS was automatically calculated on nongated chest computed tomography before treatment using artificial intelligence-CACS software and divided into 3 categories (0, 1–100, and >100). The associations between the CACS and CTRCD and between the CACS and MACEs were assessed by logistic regression and Fine-Gray competing-risk regression model. Nelson–Aalen cumulative risk curve was performed to assess the cumulative incidence of MACEs. Results: A total of 1468 patients (785 men and 683 women; 100% Asian) were enrolled, and 362 and 185 patients developed CTRCD and MACEs, respectively. Compared with a CACS of 0 (n=826), there was stepwise higher odds of CTRCD with a CACS between 1 and 100 (n=356; odds ratio, 2.587) and a CACS >100 (n=286; odds ratio, 5.239). The CACS was associated with MACEs (1–100 versus 0: subdistribution hazard ratio 3.726; >100 versus 0: subdistribution hazard ratio 7.858; all P <0.001). Competing risk-adjusted MACEs rates for patients with a CACS of 0, 1 to 100, and >100 were 1.21%, 8.43%, and 11.19%, respectively, at 3 years, and 3.27%, 16.01%, 31.12%, respectively, at 5 years. Conclusions: The automatic CACS derived from chest computed tomography before treatment was helpful to identify high-risk patients of CTRCD and MACE and guide clinicians to implement cardiovascular protection strategies in patients with diffuse large B-cell lymphoma who received anthracycline-based chemotherapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circimaging.122.014829

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shen, H., Lian, Y., Yin, J., Zhu, M., Yang, C., Tu, C., Peng, Y., Li, X., & Zhang, J.
Affiliations
  • Chongqing University (CN)
  • First Affiliated Hospital of Zhengzhou University (CN)
  • Guangzhou Medical University (CN)
Corresponding author
  • Shen, Hesong
  • Lian, Yanbang
  • Yin, Jinxue
Venue
Circulation: Cardiovascular Imaging
Published
2023-02
Volume
16
Issue
2
Pages
e014829-e014829
ISSN
  • 1941-9651 (ISSN-L)
  • 1942-0080
OpenAlex
W4319334056
Cited by
30
References
29
Citations by year
2026: 8 · 2025: 12 · 2024: 8 · 2023: 2
FWCI
5.91
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation Cardiovascular Imaging (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
Keywords
coronary artery calcium score, diffuse large B-cell lymphoma, anthracycline chemotherapy, cancer therapy-related cardiac dysfunction, major adverse cardiovascular events, cardiovascular risk stratification, artificial intelligence, chest CT, cardiotoxicity, risk prediction model, competing risk analysis, cumulative incidence function, lymphoma treatment outcomes, Asian patients
MeSH terms
Heart Disease Risk Factors, Artificial Intelligence, Calcium, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Predictive Value of Tests, Prognosis, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Lymphoma, Large B-Cell, Diffuse, Coronary Angiography, Risk Assessment, Anthracyclines, Vascular Calcification

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review